Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist
Abu-Baker M Abdel-Aal, Vani Lakshminarayanan, Pamela Thompson, Nitin Supekar, Judy M Bradley, Margreet A Wolfert, Peter A Cohen, Sandra J Gendler, Geert-Jan Boons
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist'. Together they form a unique fingerprint.